Physician profile
Navin Jain
NPI 1083611875
$14,717.00
in general payments reported to CMS, 2019-2025
45 companies · $3,081 in 2025
The $3,081 reported for 2025 was more than what 83% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,496 · 2020: $1,223 · 2021: $1,384 · 2022: $1,967 · 2023: $2,453 · 2024: $3,113 · 2025: $3,081.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,976 · Education: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,975.95 |
| Education | $671.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,405.93 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $2,062.64 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,527.39 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Harmony Biosciences LLC | $1,009.10 | 2021-2025 | Wakix |
| Regeneron Healthcare Solutions, INC. | $896.82 | 2019-2025 | Dupixent |
| Baxter Healthcare | $743.19 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Jazz Pharmaceuticals INC. | $711.06 | 2019-2025 | |
| Grifols USA, LLC | $655.97 | 2019-2025 | Prolastin-C Liquid |
| Axsome Therapeutics, INC. | $578.86 | 2023-2025 | Sunosi |
| Genzyme Corporation | $505.29 | 2019-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $479.53 | 2023-2025 | Lumryz |
| Mylan Specialty L.P. | $336.98 | 2019-2024 | Yupelri, Yupelri |
| Inspire Medical Systems, INC. | $327.21 | 2023-2025 | Inspire |
| Electromed, INC. | $295.51 | 2019-2025 | Smartvest |
| Actelion Pharmaceuticals US, INC. | $178.45 | 2019-2024 | Uptravi, Opsumit |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $155.11 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Takeda Pharmaceuticals U.S.A., INC. | $144.43 | 2020-2025 | Glassia |
| Eisai INC. | $126.56 | 2020-2022 | |
| Pfizer INC. | $116.46 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $107.99 | 2020-2025 | |
| Genentech USA, INC. | $106.71 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $106.41 | 2019-2023 | Xarelto |
| Amgen INC. | $105.68 | 2023-2025 | Tezspire |
| Merck Sharp & Dohme LLC | $105.17 | 2019-2022 | |
| Insmed, INC. | $90.89 | 2022-2025 | Arikayce, Brinsupri |
| Pulmonx Corporation | $87.33 | 2021-2025 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Verona Pharma, INC. | $82.81 | 2025 | Ohtuvayre |
| Inogen, INC. | $71.47 | 2022-2023 | Inogen |
| United Therapeutics Corporation | $69.58 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $63.52 | 2019 | |
| Circassia INC. | $60.93 | 2019 | |
| Advanced Respiratory, INC | $57.53 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $49.83 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.97 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $48.09 | 2019-2022 | |
| Phadia US INC. | $33.42 | 2023-2024 | Immunocap |
| Lilly USA, LLC | $29.11 | 2025 | Zepbound |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.40 | 2024 | Lifevest |
| Fisher & Paykel Healthcare INC | $18.40 | 2023 | Fisher & Paykel Healthcare |
| Idorsia Pharmaceuticals US INC | $16.78 | 2023 | Quviviq |
| Ani Pharmaceuticals, INC. | $16.15 | 2024 | Purified Cortrophin Gel |
| Azurity Pharmaceuticals, INC. | $15.86 | 2025 | Horizant |
| Tetraphase Pharmaceuticals, INC. | $15.64 | 2020 | |
| Breas Medical, INC. | $13.84 | 2024 | Vivo 45 Ls |
| Breathe Technologies, INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Navin Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.